The Global Point of Care Molecular Diagnostics Industry is positioned for unprecedented expansion, according to the latest forecast by Future Market Insights (FMI). With a projected valuation of US$ 4.4 billion in 2023, this dynamic industry is on track to reach an impressive US$ 11.1 billion by 2033, reflecting a robust Compound Annual Growth Rate …